Working together to advance cell manufacturing
CMaT will enable robust, scalable, low-cost biomanufacturing of high-quality therapeutic cells to bring affordable, curative therapies against incurable chronic diseases.
A partnership with the National
Cell Manufacturing Consortium
When manipulating the functions of cells, researchers need to take a multidisciplinary approach.
Researchers have demonstrated an integrated technique for monitoring specific biomolecules -- such as growth factors -- that could indicate the health of living cell cultures produced for the burgeoning field of cell-based therapeutics.
The CMaT international research experience (IRE) sponsors international travel for U.S. based graduate students to engage in research with partner universities.